Laurie Ann Ximénez-Fyvie, head of the Molecular Genetics laboratory at UNAM, explains that the different international collaborations in the development of the vaccine against covid-19 Patria cast doubt on whether it is actually an entirely Mexican achievement.
The specialist comments that the process to test any drug in phase 3 can be long, and it is strange that the Mexican government already has a calendar for the key tests of this biologic.